Literature DB >> 17619880

Selective expansion of the CD14(+)/CD16(bright) subpopulation of circulating monocytes in patients with hemophagocytic syndrome.

N Takeyama1, T Yabuki, T Kumagai, S Takagi, S Takamoto, H Noguchi.   

Abstract

Overproduction of proinflammatory cytokines is characteristic of hemophagocytic syndrome (HPS), a highly lethal inflammatory disease. Peripheral blood monocytes include two distinct subpopulations according to surface antigen expression: a major type, CD14(+)/CD16(-) (classical monocytes), and a minor type, CD14(+)/CD16(bright) (proinflammatory monocytes). Among peripheral blood monocytes from HPS patients, CD14(+)/CD16(bright) cells were increased, together with lipopolysaccharide-induced production of tumor necrosis factor (TNF)-alpha and interleukin (IL)-6. By three-color immunofluorescence, CD14(+)/CD16(bright) monocytes exhibited more intense human leukocytic antigen DR than CD14(+)/CD16(-) monocytes, consistent with greater maturity. Serum IL-6, TNF-alpha, and IL-8 were increased in HPS patients. A sensitive inflammatory marker, neutrophil CD64 expression, also was significantly elevated in HPS patients. In conclusion, expansion of proinflammatory monocytes and increased expression of neutrophil CD64 appeared to be important in the pathophysiology of HPS. Expansion of CD14(+)/CD16(bright) monocytes and neutrophil CD64 expression could serve as indicators of the inflammatory state in HPS.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17619880     DOI: 10.1007/s00277-007-0332-4

Source DB:  PubMed          Journal:  Ann Hematol        ISSN: 0939-5555            Impact factor:   3.673


  7 in total

1.  Activation of T-cell receptor signaling in peripheral T-cell lymphoma cells plays an important role in the development of lymphoma-associated hemophagocytosis.

Authors:  Jun An; Hiroshi Fujiwara; Koichiro Suemori; Toshiyuki Niiya; Taichi Azuma; Kazushi Tanimoto; Toshiki Ochi; Yoshiki Akatsuka; Junichi Mineno; Hidetoshi Ozawa; Fumihiko Ishikawa; Kiyotaka Kuzushima; Masaki Yasukawa
Journal:  Int J Hematol       Date:  2011-01-13       Impact factor: 2.490

2.  Biomarkers to Diagnose Early Arthritis in Patients With Psoriasis.

Authors:  Ya-Hui Grace Chiu; Christopher T Ritchlin
Journal:  Psoriasis Forum       Date:  2012

3.  NP001 regulation of macrophage activation markers in ALS: a phase I clinical and biomarker study.

Authors:  Robert G Miller; Rongzhen Zhang; Gilbert Block; Jonathan Katz; Richard Barohn; Edward Kasarskis; Dallas Forshew; Vidhya Gopalakrishnan; Michael S McGrath
Journal:  Amyotroph Lateral Scler Frontotemporal Degener       Date:  2014-09-05       Impact factor: 4.092

4.  Circulating inflammatory monocytes contribute to impaired influenza vaccine responses in HIV-infected participants.

Authors:  Varghese K George; Suresh Pallikkuth; Rajendra Pahwa; Lesley R de Armas; Stefano Rinaldi; Li Pan; Savita Pahwa
Journal:  AIDS       Date:  2018-06-19       Impact factor: 4.177

5.  Increased PD-1 Expression and Altered T Cell Repertoire Diversity Predict Mortality in Patients with Septic Shock: A Preliminary Study.

Authors:  Atsutoshi Tomino; Masanobu Tsuda; Ruri Aoki; Yuka Kajita; Masamitsu Hashiba; Tsuguaki Terajima; Hideki Kano; Naoshi Takeyama
Journal:  PLoS One       Date:  2017-01-10       Impact factor: 3.240

6.  A distinct peripheral blood monocyte phenotype is associated with parasite inhibitory activity in acute uncomplicated Plasmodium falciparum malaria.

Authors:  Pattamawan Chimma; Christian Roussilhon; Panudda Sratongno; Ronnatrai Ruangveerayuth; Kovit Pattanapanyasat; Jean-Louis Pérignon; David J Roberts; Pierre Druilhe
Journal:  PLoS Pathog       Date:  2009-10-23       Impact factor: 6.823

7.  CD16 (FcRgammaIII) as a potential marker of osteoclast precursors in psoriatic arthritis.

Authors:  Yahui Grace Chiu; Tianmeng Shao; Changyong Feng; Kofi A Mensah; Michael Thullen; Edward M Schwarz; Christopher T Ritchlin
Journal:  Arthritis Res Ther       Date:  2010-01-26       Impact factor: 5.156

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.